Kalamarides et al., 2024)
Lovric-Bencic M, Sikiric P, Hanzevacki JS, Seiwerth S, Rogic D, Kusec V, et al
The images or other third party material in this article are included in the articles Creative Commons license, unless indicated otherwise in the credit line
Strict liability principles hold athletes accountable for any prohibited substance detected in their system, regardless of intent or origin
Rarely, a developing fetus with preexisting liver disease can develop neonatal hemochromatosis
According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common: may affect more than 1 in 10 people) Diarrhoea and constipation (very common) Vomiting and abdominal pain (very common) Decreased appetite and dyspepsia (very common) Most gastrointestinal adverse effects are mild to moderate in severity and tend to diminish over time as the body adjusts to treatment